Further insights into the anti-PF4/heparin IgM immune response
- 1 January 2016
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 115 (04), 752-761
- https://doi.org/10.1160/th15-08-0654
Abstract
Anti-platelet factor 4 (PF4)/heparin antibodies are not only the cause of heparin-induced thrombocytopenia but might also play a role in the antibacterial host defence. Recently, marginal zone (MZ) B cells were identified to be crucial for anti-PF4/heparin IgG antibody production in mice. Combining human studies and a murine model of polymicrobial sepsis we further characterised the far less investigated anti-PF4/heparin IgM immune response. We detected anti-PF4/heparin IgM antibodies in the sera of paediatric patients < 6 months of age after cardiac surgery and in sera of splenectomised mice subjected to polymicrobial sepsis. In addition, PF4/heparin-specific IgM B cells were not only found in murine spleen, but also in peritoneum and bone marrow upon in vitro stimulation. Together, this indicates involvement of additional B cell populations, as MZ B cells are not fully developed in humans until the second year of life and are restricted to the spleen in mice. Moreover, PF4/heparin-specific B cells were detected in human cord blood upon in vitro stimulation and PF4-/- mice produced anti-PF4/heparin IgM antibodies after polymicrobial sepsis. In conclusion, the anti-PF4/heparin IgM response is a potential innate immune reaction driven by a B cell population distinct from MZ B cells. Supplementary Material to this article is available online at www.thrombosis-online.com. * Authors contributed equally to this work.This publication has 36 references indexed in Scilit:
- Marginal zone B cells: virtues of innate-like antibody-producing lymphocytesNature Reviews Immunology, 2013
- B-1 B Cell Development in the Fetus and AdultImmunity, 2012
- B‐1 cells in the bone marrow are a significant source of natural IgMEuropean Journal of Immunology, 2011
- Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−The Journal of Experimental Medicine, 2011
- Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positiveJournal of Thrombosis and Haemostasis, 2010
- Optimization of a murine immunization model for study of PF4/heparin antibodiesJournal of Thrombosis and Haemostasis, 2009
- Dual role for B-1a cells in immunity to influenza virus infectionThe Journal of Experimental Medicine, 2008
- Heparin-Induced ThrombocytopeniaThe New England Journal of Medicine, 2006
- Implications for Induction of Autoimmunity via Activation of B-1 Cells byHelicobacter pyloriUreaseInfection and Immunity, 2006
- A new nomenclature for B cellsImmunology Today, 1991